Indefinite Delivery Contract 36C25025D0085

Award Date 9/1/25
Last Date to Order 8/31/30
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, an Indefinite Delivery Contract (IDC) to provide molecular pathology products and services. Under this IDC, the VA has issued multiple firm fixed-price delivery orders to Roche Diagnostics over a 5-year period, with a total ceiling value of $3,000,000. The delivery orders will supply clinical chemistry analyzers, reagents, test...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for immunochemistry and immunohistochemistry laboratory testing services. The single-award IDC, valued at $2.3 million, was awarded on November 13, 2020 and has an ultimate completion date of November 12, 2025. Under this IDC, the VA has placed multiple firm fixed price delivery orders with Roche...
The Department of Veterans Affairs Veterans Health Administration has awarded Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a single-award indefinite delivery contract (IDC) to provide Roche brand reagents and consumables. The $100,685.04 firm fixed price delivery order has a period of performance through February 2027 and does not utilize any set-asides. Roche Diagnostics Corp, a foreign-owned for-profit manufacturer, is an established federal contractor that has...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 9 awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The base contract, valued at $922,772, provides the VA with an ongoing vehicle to procure influenza A/B and COVID-19 testing supplies and services without socioeconomic set-asides. Under this IDC, the VA has issued multiple firm...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) valued at $167,300 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical laboratory equipment. The contract, which has a period of performance through June 30, 2030, provides for the delivery of Roche LIAT consumables, including test kits and controls for COVID-19, Influenza A/B, RSV, and Group A Streptococcus testing, to the VA's Veterans...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 16 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $1,990,634.10 contract is for the provision of COBAS 6800 SYSTEM, ASSAYS, REAGENTS AND SUPPLIES. It is a Firm Fixed Price Delivery Order with an ultimate completion date of July 31, 2030. Roche Diagnostics Corporation, a...
This is an Indefinite Delivery Contract (IDC) awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and medical laboratory equipment. The contract, with a ceiling value of $247,853.70, is for the provision of Roche HE600 and Benchmark reagents to support the VA's healthcare operations. The contract includes a $49,570.74 delivery order that adds new line items to the existing IDC. The...
This Indefinite Delivery Contract was awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract is for the provision of SARS-CoV-2 and cytomegalovirus (CMV) test and control kits, with a total ceiling value of $488,315.80. The contract includes two task orders: a $97,663.16 firm fixed-price delivery order with a completion date of May 31, 2026, and a $57,471.16 firm...
The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at up to $15,466,932.92, is for the rental of Molecular Diagnostics Analyzers and associated reagents to support the VA's laboratory testing capabilities across its healthcare facilities. Two delivery orders have been issued...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics. The $487,747.35 BPA contract, issued under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III), will provide the VA with critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. The contract supports the provision of...
  • 36C25025D0085
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The federal agency, the Department of Veterans Affairs Veterans Health Administration (VA), awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The IDC has a ceiling value of $667,159.30 and an ultimate completion date of August 31, 2030, for the provision of REAGENTS AND CONSUMABLES.

Under this IDC, a $135,281.86 Delivery Order was awarded to Roche Diagnostics for COBA REAGENTS/CONSUMABLES, with a period of performance from September 1, 2025, to August 31, 2026. The original solicitation was issued by the VA to procure an FDA-approved, fully automated molecular diagnostic system capable of performing quantitative and qualitative testing for various infectious diseases, including HCV, HIV, CT/NG, TV/MG, HIV 1/2, EBV, CMV, and HPV. The contract aims to enhance the VA's in-house testing capabilities and align with the agency's strategic plan for improving veteran healthcare services. The contract will be a one-year base agreement with four optional one-year extensions, and the contractor will be responsible for system validation, technical support, and compliance with CLIA and CLSI standards.

Generated 9/5/25, 9:49 AM